Brief Report: Activity of Imatinib in a Patient with Platelet-Derived-Growth-Factor Receptor Positive Malignant Solitary Fibrous Tumor of the Pleura
- 1 August 2008
- journal article
- case report
- Published by Elsevier in Journal of Thoracic Oncology
- Vol. 3 (8) , 938-941
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Clinical and Molecular Studies of the Effect of Imatinib on Advanced Aggressive Fibromatosis (desmoid tumor)Journal of Clinical Oncology, 2006
- Patterns of Recurrence and Long-Term Survival After Curative Resection of Localized Fibrous Tumors of the PleuraClinical Lung Cancer, 2005
- Solitary Fibrous Tumors of the Pleura: Surgical Outcome and Clinical CourseThe Annals of Thoracic Surgery, 2005
- Imatinib mesylate in chordomaCancer, 2004
- 328 Clinical and molecular studies of the effect of imatinib on advanced aggressive fibromatosis (desmoid tumors)European Journal of Cancer Supplements, 2004
- Progression-free survival in gastrointestinal stromal tumours with high-dose imatinib: randomised trialThe Lancet, 2004
- Gastrointestinal stromal tumors (GISTs) with KIT and PDGFRA mutations have distinct gene expression profilesOncogene, 2004
- PDGFRA Activating Mutations in Gastrointestinal Stromal TumorsScience, 2003
- Response of extraabdominal desmoid tumors to therapy with imatinib mesylateCancer, 2002
- Molecular Targeting of Platelet-Derived Growth Factor B by Imatinib Mesylate in a Patient With Metastatic Dermatofibrosarcoma ProtuberansJournal of Clinical Oncology, 2002